← Open Payments lookup

EDWARD TOBEY: Open Payments

NPI 1306846712 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,520 in 138 payments from 16 companies in 2025. Trend: 2023 $1,507 · 2024 $2,093 · 2025 $2,520

Food & beverage: $2,520
CompanyPaymentsAmount
ABBVIE INC.27$608
Otsuka America Pharmaceutical, Inc.32$595
Vanda Pharmaceuticals Inc.22$291
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$232
Teva Pharmaceuticals USA, Inc.9$140
Axsome Therapeutics, Inc.5$114
HARMONY BIOSCIENCES LLC4$114
Neurocrine BioSciences, Inc.4$93
E.R. Squibb & Sons, L.L.C.4$74
Takeda Pharmaceuticals U.S.A., Inc.4$68

Products named: REXULTI, VRAYLAR, FANAPT, CAPLYTA, WAKIX, INGREZZA, AUSTEDO XR, COBENFY.

Industry payments across TX — which companies pay providers there.